Search research articles
Contact Us
Filters
Showing results (91-100 of 184) with videos related to
Page
of 19
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
September 15, 2020
Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor
Andrew L Lin, Mark T A Donoghue, Sharon L Wardlaw, et al.
Journal of Clinical Medicine
|
July 3, 2019
A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
Agnieszka Kolasinska-Ćwikła, Mariola Pęczkowska, Jarosław B Ćwikła, et al.
European Journal of Endocrinology
|
August 14, 2014
GEPNETs update: Radionuclide therapy in neuroendocrine tumors
Wouter A van der Zwan, Lisa Bodei, Jan Mueller-Brand, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2008
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 29, 2003
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study
Lisa Bodei, Marta Cremonesi, Stefania Zoboli, et al.
Plos One
|
June 28, 2019
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
Mark Kidd, Ignat A Drozdov, Somer Matar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
Valentina Ambrosini, Davide Campana, Lisa Bodei, et al.
Annals of Surgical Oncology
|
September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
Emilio Bertani, Nicola Fazio, Davide Radice, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 24, 2021
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
Sonya Park, Ashwin Singh Parihar, Lisa Bodei, et al.
Surgery
|
March 4, 2014
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach
Emilio Bertani, Nicola Fazio, Edoardo Botteri, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 184) with videos related to
Sort By:
Page
of 19
The Journal of Clinical Endocrinology and Metabolism
|
September 15, 2020
Approach to the Treatment of a Patient with an Aggressive Pituitary Tumor
Andrew L Lin, Mark T A Donoghue, Sharon L Wardlaw, et al.
Journal of Clinical Medicine
|
July 3, 2019
A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
Agnieszka Kolasinska-Ćwikła, Mariola Pęczkowska, Jarosław B Ćwikła, et al.
European Journal of Endocrinology
|
August 14, 2014
GEPNETs update: Radionuclide therapy in neuroendocrine tumors
Wouter A van der Zwan, Lisa Bodei, Jan Mueller-Brand, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2008
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 29, 2003
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study
Lisa Bodei, Marta Cremonesi, Stefania Zoboli, et al.
Plos One
|
June 28, 2019
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
Mark Kidd, Ignat A Drozdov, Somer Matar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors
Valentina Ambrosini, Davide Campana, Lisa Bodei, et al.
Annals of Surgical Oncology
|
September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
Emilio Bertani, Nicola Fazio, Davide Radice, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 24, 2021
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
Sonya Park, Ashwin Singh Parihar, Lisa Bodei, et al.
Surgery
|
March 4, 2014
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach
Emilio Bertani, Nicola Fazio, Edoardo Botteri, et al.
Page
of 19